Saturday, 31 October 2026European Markets

ITERA And UNION TECH.INFOR. Have A High Dividend Yield And Return On Equity In The Information Technology Services Industry.

Loading stream...

(vianews) - itera (itera.ol) is among this list of stock assets with the highest dividend rate and return on equity on the information technology services industry.

financial asset price forward dividend yield return on equity
itera (itera.ol) kr12.10 2.5% 116.49%
union tech.infor. (fpg.pa) €0.62 1% 7.99%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. itera (itera.ol)

2.5% forward dividend yield and 116.49% return on equity

itera asa, together with its subsidiaries, designs, develops, and operates digital solutions for companies and organizations in norway, denmark, and slovakia. it offers data, artificial intelligence and analytics, development and architecture, test and quality assurance solutions, as well as cloud and application services. the company delivers projects and services in the strategy and consulting, customer experience, and technology and cloud transformation areas. itera asa was founded in 1989 and is based in oslo, norway.

earnings per share

as for profitability, itera has a trailing twelve months eps of kr0.76.

pe ratio

itera has a trailing twelve months price to earnings ratio of 15.92. meaning, the purchaser of the share is investing kr15.92 for every norwegian krone of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 116.49%.

revenue growth

year-on-year quarterly revenue growth grew by 8.1%, now sitting on 871.58m for the twelve trailing months.

volume

today's last reported volume for itera is 14345 which is 68.82% below its average volume of 46018.

more news about itera.

2. union tech.infor. (fpg.pa)

1% forward dividend yield and 7.99% return on equity

union technologies informatique group s.a., an it service company, provides consulting and engineering services to banking, finance, insurance, retirement, industry, and service sectors in france and internationally. the company offers project management, technical assistance, and system integration services, as well as distributes application software packages. its software products include optima, edi-one, and net400. the company was incorporated in 1986 and is headquartered in levallois-perret, france. union technologies informatique group s.a. is a subsidiary of law informatique.

earnings per share

as for profitability, union tech.infor. has a trailing twelve months eps of €0.04.

pe ratio

union tech.infor. has a trailing twelve months price to earnings ratio of 15.5. meaning, the purchaser of the share is investing €15.5 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.99%.

revenue growth

year-on-year quarterly revenue growth grew by 4.7%, now sitting on 21.81m for the twelve trailing months.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, union tech.infor.'s stock is considered to be overbought (>=80).

more news about union tech.infor..

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com
ITERA And UNION TECH.INFOR. Have A High Dividend Yield And Return On Equity In The Information Technology Services Industry. | ViaNews EU